Diabetes & CV Disease
Sort by:
Houston Methodist Hospital
What Is Lifestyle Medicine and Why Should it Play a Bigger Role in Our Current Healthcare System
FEATURING
Garth Davis
- 504 views
- March 22, 2022
Mount Sinai Advanced Innovations in Heart Failure
Medical Therapy for Heart Failure in 2022
FEATURING
Anuradha Lala-Trindade
- 1,021 views
- March 2, 2022
- 11
Emory Diabetes Education Training Academy
Update in Diabetes and Cardiovascular Health
FEATURING
Guillermo Umpierrez
- 2,099 views
- February 17, 2022
- 11
ACC 2022 Conference Coverage
Hot Topics in Heart Failure ACC.22
FEATURING
Nasrien Ibrahim
- 3,493 views
- April 22, 2022
- 33
Houston Methodist DeBakey Heart and Vascular Center
What Are the Key Components of Primary CVD Prevention from ACC/AHA Guidelines?
FEATURING
Salim Virani
- 1,876 views
- November 25, 2020
- 11
Susan Brian
The Differences Between the Products of GLP1's and GLP/GIPs
- 2,104 views
- January 29, 2024
- 36
The Texas Heart Institute
Use of Finerenone in Patients with Diabetes Who Have Kidney Disease
FEATURING
George Bakris
- 2,248 views
- September 7, 2023
- 25
Primary Care Education Consortium
A Pathophysiologic Approach for Treating Type 2 Diabetes: Part 2
FEATURING
Eden Miller
- 2,357 views
- November 30, 2023
- 20
Diana Isaacs
Clinical Pearls & Updates on Incretins: The Diabetes Drugs Taking Hollywood by Storm
- 3,383 views
- August 29, 2023
- 19
ADA 2023 Insights
ADA 2023 Insights: Role for Amylin in Monotherapy and Combination Therapy for Obesity
FEATURING
David Lau
- 1,371 views
- July 14, 2023
- 11
National Lipid Association
Plant-based Diets for Improving Lipids
FEATURING
Kim Williams
- 3,509 views
- March 25, 2019
- 35
University of Colorado Department of Medicine
Updates in Nephrology
FEATURING
Anna Jovanovich
- 2,858 views
- March 7, 2023
- 19
Cardiometabolic Health Congress (CMHC)
SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes
FEATURING
Lance Sloan
- 7,999 views
- June 17, 2019
- 48
ACC 2023 Conference Coverage
ACC 2023: Evaluation of the Mechanism of Benefit for Dapagliflozin in HFpEF - An Invasive Hemodynamic Randomized Trial
FEATURING
Barry Borlaug
- 1,317 views
- March 15, 2023
- 9
Lucia Novak
Dysglycemia in T2D: When Do We Need To Add a Mealtime Insulin? How Does Lispro aabc Prevent Dysglycemia?
- 516 views
- February 5, 2021
- 4
Cedars Sinai
SGLT2 Inhibitors: Are They the Modern-Day Statins? Insights from Recent Cardiorenal Metabolic Outcome Trial
FEATURING
Sanjay Kaul,
Milton Packer
- 1,785 views
- February 7, 2022
- 9
Physicians Committee for Responsible Medicine
What Are the Effects of Dietary Fiber on Cardiometabolic Health?
FEATURING
Hana Kahleova
- 646 views
- December 2, 2020
- 3
Cleveland Clinic | 12th Annual Obesity Summit
Management of Hypertension and Hyperlipidemia in Type 2 Diabetes
FEATURING
Steven Nissen
- 2,151 views
- December 3, 2017
- 8
KDIGO
Cardiovascular Benefits Associated with Current Pharmacotherapies in Patients with CKD and Diabetes
FEATURING
Erin Michos
- 343 views
- January 24, 2022
- 4
Christos Argyropoulos
Diabetic Kidney Disease Treatment: When to Use SGLT2 Inhibitors & Who Should Prescribe Them?
- 1,256 views
- December 14, 2020
- 3